{"id":70072,"date":"2026-05-01T06:08:34","date_gmt":"2026-05-01T06:08:34","guid":{"rendered":"https:\/\/medsbase.com\/diabetes-starter-pack\/"},"modified":"2026-05-01T10:49:10","modified_gmt":"2026-05-01T10:49:10","slug":"diabetes-starter-pack","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/diabetes-starter-pack\/","title":{"rendered":"Pachet de pornire pentru diabet \u2014 Glycomet SR 1000 + Glycomet-GP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fffbea;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 22px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 10px 0;font-size:20px;\">R\u0103spuns rapid \u2014 Ce este Pachetul de Start pentru Diabet?<\/h3>\n<p style=\"margin:0;\">Pachetul de Start pentru Diabet de la MedsBase combin\u0103 <strong>metformin cu eliberare prelungit\u0103 1000 mg<\/strong> (Glycomet SR de la USV) cu <strong>combina\u021bia de metformin + glimepirid\u0103 500 mg + 2 mg<\/strong> (Glycomet-GP) \u2014 cele dou\u0103 medicamente cel mai frecvent prescrise ca tratament de prim\u0103 linie \u0219i de intensificare pentru diabetul zaharat de tip 2 nou-diagnosticat, conform recomand\u0103rilor ADA, EASD \u0219i NICE 2024. Metforminul cu eliberare prelungit\u0103 asigur\u0103 efectul de baz\u0103 de reducere a glicemiei; combina\u021bia de metformin-glimepirid\u0103 adaug\u0103 activitate secretagog\u0103 de insulin\u0103 pentru pacien\u021bii care necesit\u0103 un agent de a doua linie mai puternic. Op\u021biuni de aprovizionare: 1, 3 sau 6 luni. Doar sub supraveghere medical\u0103 specializat\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce con\u021bine Pachetul de Start pentru Diabet<\/h2>\n<ul>\n<li><strong><a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR 1000 mg<\/a><\/strong> (metformin hidroclorid cu eliberare prelungit\u0103, USV India). Agent oral de prim\u0103 linie pentru diabetul zaharat de tip 2 conform tuturor recomand\u0103rilor majore din 1998 p\u00e2n\u0103 \u00een prezent. Mecanism: activarea AMPK \u00een ficat suprima gluconeogeneza hepatic\u0103 (sursa dominant\u0103 a hiperglicemiei \u00een postabsorbtie la DZ2), cu efecte secundare asupra GLP-1, microbiomului intestinal \u0219i sensibilit\u0103\u021bii periferice la insulin\u0103. Formularea cu eliberare prelungit\u0103 reduce la jum\u0103tate efectele secundare gastrointestinale ale metforminului cu eliberare imediat\u0103.<\/li>\n<li><strong><a href=\"https:\/\/medsbase.com\/ro\/glycomet-gp\/\">Glycomet-GP 500 mg + 2 mg<\/a><\/strong> (metformin + glimepirid\u0103). Adaug\u0103 o sulfoniluree \u2014 glimepirida se leag\u0103 de subunitatea SUR1 a canalelor K-ATP pancreatice \u0219i declan\u0219eaz\u0103 secre\u021bia de insulin\u0103. Utilizat\u0103 ca agent de intensificare de a doua linie c\u00e2nd HbA1c r\u0103m\u00e2ne peste \u021bint\u0103 sub tratament cu metformin singur, mai ales c\u00e2nd inhibitorii SGLT-2 sau agonii\u0219tii GLP-1 nu sunt disponibili sau accesibili financiar.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">De ce s\u0103 combina\u021bi aceste dou\u0103 produse?<\/h2>\n<p>Pentru diabetul zaharat de tip 2 nou-diagnosticat, protocolul standard ADA\/EASD este: metformin mai \u00eent\u00e2i, cre\u0219terea dozei treptat p\u00e2n\u0103 la 2000 mg\/zi pe parcursul a 4\u20138 s\u0103pt\u0103m\u00e2ni, verificarea HbA1c la 12 s\u0103pt\u0103m\u00e2ni. Dac\u0103 HbA1c r\u0103m\u00e2ne peste \u021bint\u0103 (de obicei &gt; 7%) \u0219i nu exist\u0103 indica\u021bii specifice pentru SGLT-2 \/ GLP-1 (f\u0103r\u0103 ASCVD, BCR sau IC stabilite), o sulfoniluree precum glimepirida este cea mai utilizat\u0103 op\u021biune accesibil\u0103 de a doua linie \u00een multe regiuni ale lumii.<\/p>\n<p>Acest pachet include at\u00e2t regimul de baz\u0103, c\u00e2t \u0219i regimul intensificat \u00eentr-o singur\u0103 expediere. Pacien\u021bii care tolereaz\u0103 bine metformina la doza de 2000 mg\/zi pot continua doar cu Glycomet SR (utiliza\u021bi nivelul de 6 luni ca aprovizionare de \u00eentre\u021binere). Pacien\u021bii al c\u0103ror HbA1c r\u0103m\u00e2ne ridicat pot intensifica tratamentul prin ad\u0103ugarea Glycomet-GP \u2014 \u00eenlocuind de obicei una din dozele de metformin\u0103 SR cu combina\u021bia pentru a men\u021bine doza total\u0103 de metformin\u0103 aproximativ constant\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Pentru cine este destinat acest pachet<\/h2>\n<p><strong>Candida\u021bi ideali:<\/strong><\/p>\n<ul>\n<li>Adul\u021bi nou-diagnostica\u021bi cu diabet zaharat de tip 2 (HbA1c 6,5\u20139,0%) care \u00eencep terapia oral\u0103 de prim\u0103 linie<\/li>\n<li>Pacien\u021bi sub tratament cu metformin\u0103 \u00een monoterapie al c\u0103ror HbA1c nu a atins \u021binta dup\u0103 12+ s\u0103pt\u0103m\u00e2ni la doza maxim\u0103 tolerat\u0103<\/li>\n<li>Pacien\u021bi din regiuni unde inhibitorii SGLT-2 sau agonii receptorilor GLP-1 nu sunt disponibili sau accesibili financiar, iar sulfonilureele r\u0103m\u00e2n a doua linie practic\u0103<\/li>\n<li>Pacien\u021bi f\u0103r\u0103 ASCVD, HF sau CKD unde avantajele cardio-renale ale SGLT-2 \/ GLP-1 nu se aplic\u0103 \u00een mod specific<\/li>\n<\/ul>\n<p><strong>NU este potrivit pentru:<\/strong><\/p>\n<ul>\n<li>Diabet zaharat de tip 1 \u2014 necesit\u0103 \u00eenlocuire cu insulin\u0103, nu secretagogi de insulin\u0103<\/li>\n<li>HbA1c &gt; 10% cu simptome hiperglicemice \u2014 \u00eencepe\u021bi cu insulin\u0103, nu doar cu agen\u021bi orali<\/li>\n<li>eGFR &lt; 30 mL\/min \u2014 metformina este contraindivat\u0103 sub acest prag (risc de acidoz\u0103 lactic\u0103)<\/li>\n<li>Boal\u0103 acut\u0103, deshidratare, imagistic\u0103 cu substan\u021b\u0103 de contrast \u00een ultimele 48 de ore \u2014 \u00eentrerupe\u021bi temporar metformina<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 (Child-Pugh B sau C)<\/li>\n<li>Sarcina \u2014 trece\u021bi la insulin\u0103 sub supraveghere specializat\u0103; metformina poate fi continuat\u0103 \u00een unele protocoale de sarcin\u0103 legate de sindromul ovarelor polichistice (PCOS)<\/li>\n<li>Consumul ridicat de alcool \u2014 cre\u0219te riscul de acidoz\u0103 lactic\u0103 la administrarea de metformin\u0103<\/li>\n<li>Hipersensibilitate cunoscut\u0103 la sulfoniluree (reactivitate \u00eencruci\u0219at\u0103 cu antibioticele sulfamidice)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cum s\u0103 utiliza\u021bi corect pachetul<\/h2>\n<p><strong>Glycomet SR 1000 mg (metformin SR)<\/strong><\/p>\n<ul>\n<li><strong>S\u0103pt\u0103m\u00e2na 1\u20132:<\/strong> 500 mg (jum\u0103tate de tablet\u0103, despicat\u0103 dac\u0103 este posibil \u2014 sau folosi\u021bi o variant\u0103 de 500 mg) o dat\u0103 pe zi, \u00een timpul celei mai mari mese a zilei.<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2na 3\u20134:<\/strong> 500 mg de dou\u0103 ori pe zi (sau 1000 mg o dat\u0103 pe zi la cin\u0103).<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2na 5+:<\/strong> 1000 mg de dou\u0103 ori pe zi (doza \u021bint\u0103; unii pacien\u021bi tolereaz\u0103 2500 mg\/zi).<\/li>\n<li>Lua\u021bi \u00eentotdeauna \u00een timpul mesei. Formularea SR este preferabil o dat\u0103 pe zi (la cin\u0103); administrarea de dou\u0103 ori pe zi este acceptabil\u0103.<\/li>\n<li>Nu zdrobi\u021bi sau mesteca\u021bi tableta SR \u2014 anuleaz\u0103 efectul de eliberare prelungit\u0103.<\/li>\n<\/ul>\n<p><strong>Glycomet-GP 500 mg + 2 mg (la cre\u0219terea dozei)<\/strong><\/p>\n<ul>\n<li><strong>Doza de \u00eenceput:<\/strong> 1 tablet\u0103 la micul dejun. \u00cenlocuie\u0219te una din dozele de metformin\u0103 SR diminea\u021ba pentru a men\u021bine doza total\u0103 de metformin\u0103 \u00een jur de 2000 mg\/zi.<\/li>\n<li><strong>Titrarea:<\/strong> dac\u0103 HbA1c r\u0103m\u00e2ne peste \u021bint\u0103 dup\u0103 8\u201312 s\u0103pt\u0103m\u00e2ni, cre\u0219te la 1 tablet\u0103 la micul dejun \u0219i 1 tablet\u0103 la cin\u0103 \u2014 dar verific\u0103 glicemia \u00een post \u0219i monitorizeaz\u0103 hipoglicemia.<\/li>\n<li>Administreaz\u0103 cu alimente pentru a reduce riscul de hipoglicemie.<\/li>\n<li>Poart\u0103 tablete de glucoz\u0103 sau suc \u00eendulcit dac\u0103 conduci, poste\u0219ti sau faci exerci\u021bii prelungite \u2014 sulfonilureele cauzeaz\u0103 hipoglicemie, metformina singur\u0103 nu.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Siguran\u021b\u0103 \u00een utilizarea combinat\u0103<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:14px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>Avertizare hipoglicemie<\/strong><\/p>\n<p style=\"margin:0;\">Glimepirida cauzeaz\u0103 hipoglicemie; metformina nu (c\u00e2nd este folosit\u0103 singur\u0103). Odat\u0103 ce adaugi Glycomet-GP, ai un risc real de hipoglicemie pentru prima dat\u0103. Simptome: transpira\u021bie, tremur\u0103turi, foame, b\u0103t\u0103i cardiace accelerate, vedere \u00eence\u021bo\u0219at\u0103, confuzie. <strong>Poart\u0103 \u00eentotdeauna carbohidra\u021bi cu ac\u021biune rapid\u0103<\/strong> (tablete de glucoz\u0103, suc, zah\u0103r). Pacien\u021bii \u00een v\u00e2rst\u0103 \u0219i cei cu insuficien\u021b\u0103 renal\u0103 au un risc mai mare \u0219i pot necesita doze mai mici de glimepirid\u0103.<\/p>\n<\/div>\n<p>Combina\u021bia de metformin\u0103 + glimepirid\u0103 este bine studiat\u0103 \u2014 nicio interac\u021biune farmacocinetic\u0103 semnificativ\u0103 din punct de vedere clinic. Combina\u021bia a fost un regim standard de intensificare timp de peste 25 de ani.<\/p>\n<p>Monitorizeaz\u0103: deficien\u021ba de B12 la utilizarea pe termen lung a metforminei (control anual al B12 dup\u0103 4+ ani); suspendare temporar\u0103 \u00eenainte \u0219i dup\u0103 administrarea de contrast pentru imagistic\u0103 (48 de ore \u00eenainte \u0219i dup\u0103 contrast IV); limitarea alcoolului la 1\u20132 b\u0103uturi pe ocazie; modific\u0103ri ale greut\u0103\u021bii (sulfonilureele cresc u\u0219or greutatea, metformina este neutr\u0103 din acest punct de vedere); revizuirea medicamentelor la orice nou\u0103 prescrip\u021bie (multe medicamente interac\u021bioneaz\u0103 cu sulfonilureele).<\/p>\n<h2 class=\"wp-block-heading\">Program de monitorizare<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Test<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Frecven\u021b\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">HbA1c<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">La fiecare 3 luni p\u00e2n\u0103 la atingerea \u021bintei, apoi la fiecare 6 luni<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Glicemie \u00een post (glucometru acas\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Zilnic primele 4 s\u0103pt\u0103m\u00e2ni, apoi de 1\u20133 ori pe s\u0103pt\u0103m\u00e2n\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Func\u021bia renal\u0103 (creatinin\u0103, eGFR)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">De baz\u0103; la fiecare 6\u201312 luni<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Vitamina B12<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Dup\u0103 4 ani de metformin\u0103; apoi anual<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Panel hepatic<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">De baz\u0103; anual<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">Panel lipidic + TA<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;background:#f9f9f9;\">De baz\u0103; anual (diabetul zaharat de tip 2 este o afec\u021biune cu risc cardiovascular)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Este acela\u0219i lucru cu cump\u0103rarea Glycomet SR \u0219i Glycomet-GP separat?<\/h3>\n<p>Exact acelea\u0219i produse \u2014 Glycomet SR 1000 mg de la USV \u0219i Glycomet-GP 500\/2 mg, expediate \u00eempreun\u0103. Pre\u021bul pachetului este mai mic dec\u00e2t cump\u0103rarea fiec\u0103ruia separat.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 adaug componenta Glycomet-GP?<\/h3>\n<p>Dup\u0103 12 s\u0103pt\u0103m\u00e2ni la doza maxim\u0103 tolerat\u0103 de metformin\u0103, dac\u0103 HbA1c r\u0103m\u00e2ne peste \u021binta individualizat\u0103 (de obicei &gt; 7,0%). Dac\u0103 HbA1c a atins \u021binta doar cu metformin\u0103, p\u0103stra\u021bi Glycomet-GP \u00een rezerv\u0103 \u2014 mul\u021bi pacien\u021bi r\u0103spund bine la monoterapia cu metformin\u0103 timp de ani de zile.<\/p>\n<h3 class=\"wp-block-heading\">De ce aceste dou\u0103 \u0219i nu un inhibitor SGLT-2 sau un GLP-1?<\/h3>\n<p>Inhibitorii SGLT-2 (empagliflozin\u0103, dapagliflozin\u0103) \u0219i agonistii GLP-1 (semaglutid\u0103, liraglutid\u0103) sunt superiori clinic pentru pacien\u021bii cu boli cardiovasculare stabilite, insuficien\u021b\u0103 cardiac\u0103 sau boli renale cronice \u2014 reduc evenimentele cardiovasculare majore independent de sc\u0103derea glicemiei. Pentru pacien\u021bii f\u0103r\u0103 aceste indica\u021bii imperative, metformina + sulfoniluree r\u0103m\u00e2ne o op\u021biune rezonabil\u0103, accesibil\u0103 \u0219i testat\u0103 \u00een timp. Avem \u00een stoc op\u021biuni SGLT-2 (Forxiga, Jardiance, Invokana) \u0219i GLP-1 (Ozempic, Mounjaro) separat pentru pacien\u021bii care se \u00eencadreaz\u0103 \u00een aceste indica\u021bii.<\/p>\n<h3 class=\"wp-block-heading\">Metformina provoac\u0103 efecte secundare gastrointestinale?<\/h3>\n<p>Da \u2014 diareea, grea\u021b\u0103, disconfort abdominal afecteaz\u0103 20\u201330% dintre pacien\u021bii care \u00eencepe tratamentul. Formularea SR din acest pachet este aleas\u0103 special pentru c\u0103 reduce la jum\u0103tate povara gastrointestinal\u0103 comparativ cu metformina cu eliberare imediat\u0103. Dac\u0103 efectele secundare persist\u0103, \u00eencetini\u021bi titrarea (r\u0103m\u00e2ne\u021bi la 500 mg\/zi timp de 2 s\u0103pt\u0103m\u00e2ni, apoi 500 mg de dou\u0103 ori pe zi timp de 2 s\u0103pt\u0103m\u00e2ni), lua\u021bi \u00eentotdeauna cu m\u00e2ncare \u0219i lua\u021bi \u00een considerare \u00eemp\u0103r\u021birea dozei.<\/p>\n<h3 class=\"wp-block-heading\">Voi lua \u00een greutate?<\/h3>\n<p>Metformina este neutr\u0103 din punct de vedere al greut\u0103\u021bii sau u\u0219or reductoare. Glimepirida provoac\u0103 o cre\u0219tere modest\u0103 de 1\u20133 kg \u00een 6\u201312 luni \u00een medie (mediat\u0103 de insulin\u0103, dependent\u0103 de doz\u0103). Pentru pacien\u021bii care prioritizeaz\u0103 pierderea \u00een greutate, un inhibitor SGLT-2 sau un GLP-1 este o op\u021biune mai bun\u0103 de linia a doua.<\/p>\n<h3 class=\"wp-block-heading\">Pot consuma alcool?<\/h3>\n<p>Limita\u021bi-v\u0103 la 1\u20132 b\u0103uturi standard pe ocazie, cu m\u00e2ncare. Consumul excesiv sau episodic de alcool pe fond de metformin\u0103 cre\u0219te riscul (rar dar grav) de acidoz\u0103 lactic\u0103. Consumul excesiv de alcool pe fond de glimepirid\u0103 cre\u0219te riscul de hipoglicemie sever\u0103. Evita\u021bi consumul de alcool pe stomacul gol.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 sunt bolnav sau nu m\u0103n\u00e2nc o zi \u00eentreag\u0103?<\/h3>\n<p>Suspenda\u021bi ambele medicamente \u00een timpul afec\u021biunilor acute cu v\u0103rs\u0103turi, diaree sever\u0103 sau aport alimentar redus semnificativ \u2014 \u201cregulile zilelor de boal\u0103\u201d. Relua\u021bi tratamentul c\u00e2nd m\u00e2nca\u021bi normal \u0219i sunte\u021bi bine hidrata\u021bi. Hipoglicemia sever\u0103 din cauza glimepiridei \u00een timpul postului pe fond de boal\u0103 este un risc real.<\/p>\n<h3 class=\"wp-block-heading\">Cum voi \u0219ti dac\u0103 glicemia mea este prea sc\u0103zut\u0103?<\/h3>\n<p>Simptome de hipoglicemie: transpira\u021bie, tremur, foame, b\u0103t\u0103i cardiace accelerate, ame\u021beli, confuzie, vorbire \u00eencetinit\u0103, modific\u0103ri ale vederii. Trata\u021bi cu 15 g de carbohidra\u021bi cu ac\u021biune rapid\u0103 (4\u20135 comprimate de glucoz\u0103, o jum\u0103tate de pahar de suc, 3 cuburi de zah\u0103r), verifica\u021bi glicemia dup\u0103 15 minute, repeta\u021bi dac\u0103 &lt; 4 mmol\/L. Nu conduce\u021bi niciodat\u0103 \u00een stare hipoglicemic\u0103. Purta\u021bi \u00eentotdeauna comprimate de glucoz\u0103 odat\u0103 ce \u00eencepe\u021bi glimepirida.<\/p>\n<h3 class=\"wp-block-heading\">Pot pl\u0103ti cu criptomoned\u0103?<\/h3>\n<p>Da \u2014 Bitcoin, Ethereum, USDT \u0219i alte criptomonede majore prin Plisio, cu o reducere automat\u0103 de 10% la finalizarea comenzii. Vezi the <a href=\"https:\/\/medsbase.com\/ro\/crypto-payment-guide\/\">Ghid pentru pl\u0103\u021bi crypto<\/a>.<\/p>\n<h3 class=\"wp-block-heading\">Cum este expediat pachetul?<\/h3>\n<p>Ambalaj discret simplu, f\u0103r\u0103 denumiri de medicamente pe exterior. Livrare worldwide. The <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a> acoper\u0103 o reshipare gratuit\u0103 dac\u0103 coletul t\u0103u nu ajunge \u00een 20 de zile lucr\u0103toare.<\/p>\n<p><!-- mb-bundle-quantities-v1 --><\/p>\n<h2 class=\"wp-block-heading\" id=\"whats-in-each-tier\">Ce con\u021bine fiecare nivel<\/h2>\n<p>Doza standard o dat\u0103 pe zi pentru ambele comprimate. Glycomet-GP furnizeaz\u0103 comprimatul combinat glimepirid\u0103 + metformin\u0103 500 mg; Glycomet SR 1000 adaug\u0103 metformin\u0103 cu eliberare prelungit\u0103 pentru a aduce doza zilnic\u0103 total\u0103 de metformin\u0103 la \u22481500 mg, regimul de pornire cel mai frecvent pentru diabetul zaharat de tip 2 nou-diagnosticat care nu a r\u0103spuns la monoterapia cu metformin\u0103.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0 18px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px 12px;border:1px solid #ddd;text-align:left;\">Nivel<\/th>\n<th style=\"padding:10px 12px;border:1px solid #ddd;text-align:left;\">Cuprins<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px 12px;border:1px solid #ddd;vertical-align:top;white-space:nowrap;font-weight:600;\">1 Lun\u0103<\/td>\n<td style=\"padding:10px 12px;border:1px solid #ddd;\">\n<ul style=\"margin:6px 0 0 18px;padding:0;\">\n<li>Glycomet SR 1000 (metformin\u0103 XR 1000 mg) \u2014 30 comprimate<\/li>\n<li>Glycomet-GP 1 (glimepirid\u0103 1 mg + metformin\u0103 500 mg) \u2014 30 comprimate<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 12px;border:1px solid #ddd;vertical-align:top;white-space:nowrap;font-weight:600;\">3 Luni<\/td>\n<td style=\"padding:10px 12px;border:1px solid #ddd;\">\n<ul style=\"margin:6px 0 0 18px;padding:0;\">\n<li>Glycomet SR 1000 (metformin XR 1000 mg) \u2014 90 comprimate<\/li>\n<li>Glycomet-GP 1 (glimepiride 1 mg + metformin 500 mg) \u2014 90 comprimate<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px 12px;border:1px solid #ddd;vertical-align:top;white-space:nowrap;font-weight:600;\">6 Luni<\/td>\n<td style=\"padding:10px 12px;border:1px solid #ddd;\">\n<ul style=\"margin:6px 0 0 18px;padding:0;\">\n<li>Glycomet SR 1000 (metformin XR 1000 mg) \u2014 180 comprimate<\/li>\n<li>Glycomet-GP 1 (glimepiride 1 mg + metformin 500 mg) \u2014 180 comprimate<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/mb-bundle-quantities-v1 --><\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2 class=\"wp-block-heading\">De asemenea \u00een gama noastr\u0103 de medicamente pentru diabet<\/h2>\n<ul>\n<li><strong>Doar metformin\u0103:<\/strong> <a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/biciphage-1000-sr\/\">Biciphage 1000 SR<\/a><\/li>\n<li><strong>Alternative combinate metformin\u0103 + glimepirid\u0103:<\/strong> <a href=\"https:\/\/medsbase.com\/ro\/glycomet-gp\/\">Glycomet-GP<\/a><\/li>\n<li><strong>Combinat metformin\u0103 + glipizid\u0103:<\/strong> <a href=\"https:\/\/medsbase.com\/ro\/glynase-mf\/\">Glynase-MF<\/a><\/li>\n<li><strong>Inhibitori SGLT-2 (cu efect cardio-renal protector):<\/strong> <a href=\"https:\/\/medsbase.com\/ro\/invokana-canagliflozin\/\">Invokana<\/a><\/li>\n<li><strong>Inhibitori DPP-4:<\/strong> vezi \u00eentreaga <a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\">categorie Medicamente pentru diabet<\/a><\/li>\n<li><strong>Agoni\u0219ti GLP-1 (alternative la Ozempic):<\/strong> vezi ghidul nostru <a href=\"https:\/\/medsbase.com\/ro\/how-to-get-ozempic-for-weight-loss\/\">Cele mai bune alternative la Ozempic pentru 2026<\/a> ghid<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Informa\u021bii importante de siguran\u021b\u0103<\/h2>\n<p>Pachetul de start pentru diabet con\u021bine medicamente supravegheate de speciali\u0219ti \u0219i ar trebui utilizate sub supraveghere medical\u0103. Managementul diabetului de tip 2 necesit\u0103 monitorizarea regulat\u0103 a HbA1c, a func\u021biei renale \u0219i evaluarea riscului cardiovascular. Nu utiliza\u021bi metformin\u0103 dac\u0103 eGFR &lt; 30 mL\/min, \u00een insuficien\u021b\u0103 hepatic\u0103 sever\u0103 sau \u00een deshidratare activ\u0103\/boal\u0103 acut\u0103. Suspenda\u021bi metformina cu 48 de ore \u00eenainte \u0219i dup\u0103 imagistica cu contrast IV. Glimepirida provoac\u0103 hipoglicemie \u2014 purta\u021bi \u00eentotdeauna comprimate de glucoz\u0103 \u0219i notifica\u021bi un clinician dac\u0103 episoadele hipoglicemice sunt frecvente. Nu utiliza\u021bi niciunul dintre aceste medicamente \u00een diabetul de tip 1, \u00een sarcin\u0103 f\u0103r\u0103 \u00eendrumare specializat\u0103 sau \u00een hipersensibilitate cunoscut\u0103 la sulfoniluree. Opri\u021bi \u0219i solicita\u021bi \u00eengrijiri de urgen\u021b\u0103 pentru hipoglicemie sever\u0103 care nu se corecteaz\u0103 cu carbohidra\u021bi orali, dureri abdominale severe (acidoz\u0103 lactic\u0103), icter sau orice semne de hipersensibilitate sever\u0103. Aceast\u0103 pagin\u0103 are scop educa\u021bional \u0219i nu \u00eenlocuie\u0219te consultul cu un clinician calificat.<\/p>","protected":false},"excerpt":{"rendered":"<p>Pachet de pornire pentru diabet \u2014 Glycomet SR 1000 mg (metformin) + Glycomet-GP 500\/2 mg (metformin + glimepirid) \u00een pachet. Regim de prim\u0103 linie \u0219i intensificare pentru diabetul zaharat de tip 2 nou diagnosticat conform ghidurilor ADA\/EASD\/NICE. Utilizare doar sub supraveghere specializat\u0103.<\/p>","protected":false},"featured_media":70080,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3223,3231],"product_tag":[5833,5918,3251,5919,3254,5908,3255,5920,5834,5921,5922,5923],"class_list":{"0":"post-70072","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-chronic-conditions","7":"product_cat-diabetes-medication","8":"product_tag-bundle","9":"product_tag-diabetes-medication","10":"product_tag-glimepiride","11":"product_tag-glycomet","12":"product_tag-glycomet-gp","13":"product_tag-medsbase-pack","14":"product_tag-metformin","15":"product_tag-newly-diagnosed","16":"product_tag-stack","17":"product_tag-sulfonylurea","18":"product_tag-t2dm","19":"product_tag-type-2-diabetes","21":"first","22":"instock","23":"shipping-taxable","24":"purchasable","25":"product-type-variable","26":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/70072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=70072"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/70080"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=70072"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=70072"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=70072"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=70072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}